1. Home
  2. WRBY vs RCKT Comparison

WRBY vs RCKT Comparison

Compare WRBY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$22.79

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.39

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
RCKT
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
394.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
WRBY
RCKT
Price
$22.79
$3.39
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
$27.10
$29.73
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
105.88
26.37
EPS
0.06
0.66
Revenue
$871,905,000.00
N/A
Revenue This Year
$14.48
N/A
Revenue Next Year
$16.41
$64.28
P/E Ratio
$403.00
$5.30
Revenue Growth
13.04
N/A
52 Week Low
$14.96
$2.53
52 Week High
$31.00
$5.45

Technical Indicators

Market Signals
Indicator
WRBY
RCKT
Relative Strength Index (RSI) 38.52 45.12
Support Level $21.13 $3.36
Resistance Level $27.87 $3.65
Average True Range (ATR) 1.20 0.20
MACD -0.08 -0.04
Stochastic Oscillator 5.87 27.52

Price Performance

Historical Comparison
WRBY
RCKT

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: